x
Filter:
Filters applied
- Hands On
- Research ArticleRemove Research Article filter
Author
- Asirvatham, Samuel J4
- Brinker, Jeffrey A3
- Henrikson, Charles A3
- Khairy, Paul3
- Callans, David J2
- D'Avila, Andre2
- Kennergren, Charles2
- Klein, George J2
- Koruth, Jacob S2
- Kuck, Karl-Heinz2
- Ouyang, Feifan2
- Suleiman, Mahmoud2
- Abbo, Aharon1
- Arentes, Leonardo1
- Badhwar, Nitish1
- Bailin, Steven J1
- Belott, Peter1
- Belott, Peter H1
- Berger, Ronald D1
- Bozzani, Antonio1
- Bunch, T Jared1
- Burke, Martin C1
- Burri, Haran1
- Chen, Peng-Sheng1
- Chen, Qi1
Keyword
- Atrial fibrillation8
- Ablation7
- Lead extraction7
- Catheter ablation5
- Implantable cardioverter-defibrillator5
- Ventricular tachycardia5
- ventricular tachycardia5
- VT5
- AF4
- ICD4
- RV4
- atrial fibrillation3
- Congenital heart disease3
- Electrophysiology3
- implantable cardioverter-defibrillator3
- LA3
- PV3
- Accessory pathway2
- Anatomy2
- Complications2
- Coronary arteries2
- CT2
- Radiofrequency ablation2
- Transposition of the great arteries2
- VF2
Hands On
50 Results
- Hands on
How to prevent, recognize, and manage complications of lead extraction. Part II: Avoiding lead extraction—Noninfectious issues
Heart RhythmVol. 5Issue 8p1221–1223Published online: October 11, 2007- Charles A. Henrikson
- Jeffrey A. Brinker
Cited in Scopus: 11The first part of this review examined the infectious indications for lead extraction. This part discusses noninfectious indications for lead extraction and strategies for reducing the incidence of such indications. - Hands on
How to prevent, recognize, and manage complications of lead extraction. Part I: Avoiding lead extraction—Infectious issues
Heart RhythmVol. 5Issue 7p1083–1087Published online: October 11, 2007- Charles A. Henrikson
- Jeffrey A. Brinker
Cited in Scopus: 21As the number of implanted devices continues to grow, so does the need for extraction of chronic endocardial leads. Extraction carries with it considerable risk of morbidity and mortality (both intraprocedure and postprocedure), even in experienced hands. Although the evolution of technology directed at this approach has facilitated the successful removal of leads, no evidence indicates that this technology has lessened the incidence or nature of adverse events. Risks associated with lead extraction include vascular and cardiac perforation, tricuspid valve injury, various arrhythmias, sepsis, pulmonary embolism, bleeding, stroke, and myocardial infarction. - Hands on
Percutaneous extraction of coronary sinus vein and branch leads
Heart RhythmVol. 5Issue 3p491–495Published online: October 8, 2007- Martin C. Burke
Cited in Scopus: 8Extraction of cardiac leads and electrodes will continue to be a statistical necessity as electrode implant numbers and durations increase. Improved implant success and expanded indications in heart failure patients for left ventricular (LV) pacing electrodes via the coronary sinus (CS) and its branches have resulted in unique interactions among the leads, venous system, and epicardial heart that are not typically seen with traditional endocardial right heart cardiac electrodes. LV lead placement, as well as the myocardium’s response to it, requires continual evaluation to better understand the limitations that may be encountered during extraction of LV leads, especially as the mean duration of implant reaches beyond 1 year. - Hands on
European perspective on lead extraction: Part II
Heart RhythmVol. 5Issue 2p320–323Published online: September 21, 2007- Charles Kennergren
Cited in Scopus: 13If manual extraction is not successful, a locking stylet is used after the inner lumen is reamed using another stylet to remove debris. Use of a locking stylet with a very flexible tip is essential so that a tortuous lead can be negotiated. Equally important is locking the stylet as close as possible to the lead tip and not allowing the stylet to slip during the procedure. The risk of severing the sometimes fragile interpolar section of encapsulated bipolar leads is high if a positive lock close to the lead tip cannot be achieved. - Hands on
A European perspective on lead extraction: Part I
Heart RhythmVol. 5Issue 1p160–162Published online: September 21, 2007- Charles Kennergren
Cited in Scopus: 17The need for lead extraction has increased exponentially in the last decade due to greatly increased “total lead exposure time.” The increased total lead exposure time is the result of new indications for device treatment, device therapy involving more leads per patient, and longer average patient life. Improved general lead reliability noted over recent years may have decreased slightly the need for extraction; however, this effect is more than countered by recent advisories, recalls, and increased complication rates, probably related to many new centers offering device treatment. - Hands on
How to treat and identify device infections
Heart RhythmVol. 4Issue 11p1467–1470Published online: August 15, 2007- Bruce L. Wilkoff
Cited in Scopus: 41The incidence of device-related infections depends directly on the definition employed. The lack of precision is also compounded by the latency between the initiation and manifestation of the infection. It is not rare for there to be some erythema at the incision site during the first week of healing, and it is not clear that this represents infection. Less frequent, but still common, there can be a small, superficial stitch abscess, which will respond to local measures. When the diagnosis of device system infection is made, it should be made on the basis of pocket cellulitis, erosion, abscess, persistent bacteremia, or endocarditis with or without vegetation on the lead. - Hands on
Lead extraction
Heart RhythmVol. 4Issue 9p1238–1243Published online: July 19, 2007- Charles J. Love
Cited in Scopus: 16Lead extraction has grown from a “niche” procedure practiced by a select few individuals to a fairly widely disseminated technique. With the apparent increase in device infections, occluded veins and the need for device “upgrades,” more physicians are attempting to extract chronically implanted pacing and implantable cardioverter-defibrillator (ICD) leads. Unfortunately, obtaining training for this procedure is difficult outside of a training program at a center with a physician experienced in lead extraction. - Hands on
Lead extraction using the femoral vein
Heart RhythmVol. 4Issue 8p1102–1107Published online: June 18, 2007- Peter H. Belott
Cited in Scopus: 11Lead extraction using the femoral vein is an alternate approach for lead removal. It has often been dubbed “the inferior approach.” This is because today it is often reserved for use only after a failed primary approach via the implant vein. In reality it is the most versatile approach for lead removal. Prior to the advent of powered sheaths, it was frequently used as a primary approach. It is also the only approach, and the procedure of choice, for removal of broken or cut leads with free ends. - Hands on
How to select patients for lead extraction
Heart RhythmVol. 4Issue 7p978–985Published online: June 8, 2007- Michael E. Field
- Samuel O. Jones
- Laurence M. Epstein
Cited in Scopus: 32The techniques and tools for percutaneous removal of transvenous leads have undergone substantial development over the past several decades. Although the use of locking stylets and powered sheaths to free leads from encapsulated scar tissue has improved the success rate, the procedure still carries a significant risk of morbidity and mortality even in the hands of experienced operators. The threshold for lead extraction continues to evolve. The initial use of the procedure was limited to patients with life-threatening infections because of limited tools, lower success rates and high complication rates. - Hands on
How to perform linear lesions
Heart RhythmVol. 4Issue 6p803–809Published online: January 22, 2007- Pierre Jaïs
- Mélèze Hocini
- Mark D. O’Neill
- George J. Klein
- Sébastien Knecht
- Matsuo Sheiiro
- and others
Cited in Scopus: 59Atrial fibrillation (AF) is a particularly complex arrhythmia because the mechanisms leading to fibrillation are not fully understood. Accordingly, ablation strategies have evolved largely on an empirical basis. The creation of linear lesions is a fundamental strategy that is indispensable to an electrophysiology laboratory performing ablation for treatment of this arrhythmia. - Hands on
Pacing maneuvers for nonpulmonary vein sources: Part II
Heart RhythmVol. 4Issue 5p681–685Published online: January 15, 2007- Samuel J. Asirvatham
Cited in Scopus: 26Superior vena caval (SVC) potentials are similar to pulmonary vein (PV) potentials. The concepts of multiple far-field electrograms and the use of perivenous pacing and specific site and simultaneous pacing described above are equally applicable to understanding the complex electrograms found within the SVC (Figure 1). Specific sites that require pacing to determine the components of a complex electrogram found in the SVC include the right atrium (RA), azygos vein, anomalous PVs draining into the SVC, and right upper PV; in some cases, an anomalous superior branch of the right inferior PV may be required. - Hands on
Pulmonary vein–related maneuvers: Part I
Heart RhythmVol. 4Issue 4p538–544Published online: January 15, 2007- Samuel J. Asirvatham
Cited in Scopus: 36With the rapid evolution of atrial fibrillation ablation procedures, electrophysiologists have necessarily strived for simple and anatomic-based approaches. In all except the most straightforward procedures, however, questions regarding the significance of various potentials recorded on mapping and ablation catheters arise.1,2 Other articles in this series have described in detail the various approaches to atrial fibrillation ablation. In this article, the anatomic and electrophysiologic bases for pacing maneuvers used with a variety of ablation approaches are reviewed. - Hands on
How to determine and assess endpoints for left atrial ablation
Heart RhythmVol. 4Issue 3p374–380Published online: December 27, 2006- Kazuhiro Satomi
- Feifan Ouyang
- Karl-Heinz Kuck
Cited in Scopus: 4Studies have demonstrated that myocardium surrounding pulmonary vein (PV) ostia plays an important role in the initiation and perpetuation of atrial fibrillation (AF).1,2 This important finding has led to the development of segmental PV ostial isolation, circumferential ablation, and isolation around the PVs using circular linear lesions guided by three-dimensional (3D) electroanatomic mapping. Substrate modification using limited linear ablation also has been demonstrated to improve the clinical outcome after PV isolation in patients with AF inducibility. - Hands on
How to recognize, manage, and prevent complications during atrial fibrillation ablation
Heart RhythmVol. 4Issue 1p108–115Published online: December 1, 2006- Sanjay Dixit
- Francis E. Marchlinski
Cited in Scopus: 31Seminal observations by Haissaguerre et al1 demonstrating initiation of atrial fibrillation (AF) by pulmonary vein (PV) depolarizations led to the development of percutaneous catheter-based endocardial AF ablation procedure. Since its original description, the AF ablation procedure has evolved considerably. Currently, the most accepted ablation strategy involves creating circumferential radiofrequency (RF) ablation lesions around PV ostia (either individually or encircling wide areas around the left-sided and right-sided veins) with or without additional atrial lesions. - Hands on
How to use intracardiac echocardiography for atrial fibrillation ablation procedures
Heart RhythmVol. 4Issue 2p242–245Published online: November 10, 2006- David J. Callans
- Mark A. Wood
Cited in Scopus: 5Intracardiac echocardiography (ICE) has been an important tool in the development of advanced catheter ablation procedures. ICE technology now allows complete echocardiographic interrogation of all four heart chambers from the right atrium. A list of the uses for ICE in ablation procedures is given in Table 1. - Hands on
How and when to ablate the ligament of Marshall
Heart RhythmVol. 3Issue 12p1505–1507Published online: September 18, 2006- Chun Hwang
- Michael C. Fishbein
- Peng-Sheng Chen
Cited in Scopus: 32The ligament of Marshall is an epicardial vestigial fold that marks the location of the embryologic left superior vena cava. It contains the nerve, vein (vein of Marshall), and muscle tracts.1,2 The proximal portions of the muscle tracts connect directly to the coronary sinus myocardial sleeves. The distal portions of the muscle tracts extend upward into the pulmonary vein region. Figure 1 shows a postmortem human heart with the ligament of Marshall located between the left atrial (LA) appendage and left pulmonary vein. - Hands on
How to perform electrogram-guided atrial fibrillation ablation
Heart RhythmVol. 3Issue 8p981–984Published online: March 24, 2006- Koonlawee Nademanee
- Mark Schwab
- Joshua Porath
- Aharon Abbo
Cited in Scopus: 55Over the past decade, several mapping studies of human atrial fibrillation (AF) have made the following important observations: (1) Atrial electrograms during sustained atrial fibrillation have three distinct patterns: single potential, double potential, and complex fractionated potential(s) (CFAEs).1–3 (2) The distribution of these atrial electrograms during AF localizes to specific atrial sites, and these electrograms exhibit remarkable temporal and spatial stability.1,2 (3) The CFAE areas represent AF substrate sites and are important targets for AF ablation. - Hands on
How to perform encircling ablation of the left atrium
Heart RhythmVol. 3Issue 9p1105–1109Published online: March 15, 2006- Carlo Pappone
- Vincenzo Santinelli
Cited in Scopus: 25The purpose of this article is to describe the technique and results of circumferential pulmonary vein ablation (CPVA) in patients with atrial fibrillation (AF) as currently performed in Milan.1–14 Since a significant learning curve still exists with the standard procedure, we have recently developed a new system, called remote magnetic navigation and ablation, which can be performed by less experienced operators while at the same time still reducing complications.13 The results of our standard technique with manually deflectable catheters are based on about 10,000 patients with paroxysmal, persistent, or permanent AF, many of whom have structural heart disease. - Hands on
How to access the axillary vein
Heart RhythmVol. 3Issue 3p366–369Published online: November 8, 2005- Peter Belott
Cited in Scopus: 50The axillary vein has become a desirable structure for venous access for implantation of defibrillator and pacemaker leads because the vein is large, easily accessed, and can accommodate multiple leads. Furthermore, axillary vein access is not associated with problems accompanying subclavian vein access, including pneumothorax and subclavian crush syndrome.1,2 - Hands on
How to interpret electroanatomic maps
Heart RhythmVol. 3Issue 2p240–246Published online: November 8, 2005- Steven M. Markowitz
- Bruce B. Lerman
Cited in Scopus: 12Electroanatomic mapping refers to the acquisition and display of electrical information combined with spatial localization. Technologies presently available include both contact and noncontact electroanatomic mapping. This review focuses on the creation and proper interpretation of contact electroanatomic maps, which involves the sequential recording of unipolar or bipolar electrograms with a catheter in contact with the endocardium or epicardium and display of this information on a three-dimensional navigation system. - Hands on
How to analyze T-wave alternans
Heart RhythmVol. 2Issue 11p1268–1271Published online: July 29, 2005- Sergio Richter
- Gabor Duray
- Stefan H. Hohnloser
Cited in Scopus: 24Noninvasive detection of patients prone to ventricular tachyarrhythmias and sudden cardiac death using measurements of ventricular repolarization derived from the 12-lead surface ECG has received enormous interest. Among the methods introduced for this purpose are assessment of QT dispersion, determination of QT dynamics assessed from long-term ECG recordings, and morphologic assessment of T-wave patterns. Analysis of microvolt T-wave alternans has emerged as the most promising. Considerable experimental evidence links microvolt T-wave alternans to the genesis of life-threatening ventricular tachyarrhythmias. - Hands on
How to ablate left atrial flutter
Heart RhythmVol. 2Issue 10p1153–1157Published online: May 26, 2005- Dipen Shah
- Henri Sunthorn
- Haran Burri
- Pascale Gentil-Baron
Cited in Scopus: 5Typical atrial flutter ablation has become an increasingly common indication for catheter ablation, with success rates routinely exceeding 90% in most laboratories. In contrast, catheter ablation of left atrial flutter is technically challenging, and high success rates are uncommon. - Hands on
How to ablate atrioventricular nodal reentry using cryoenergy
Heart RhythmVol. 2Issue 8p893–896Published online: May 16, 2005- Peter L. Friedman
Cited in Scopus: 15Most electrophysiologists are well acquainted with the technique of radiofrequency (RF) ablation of AV nodal reentrant supraventricular tachycardia (AVNRT). This familiarity has, in turn, translated into a high degree of efficacy and safety with this method of ablation. On the other hand, catheter cryoablation is a relatively new approach for treating patients with AVNRT.1,2 Although the two ablation methods have certain similarities, understanding the unique features of cryoablation is important so that the method can be optimally used. - Hands-on—associate editor: Kenneth A. Ellenbogen
Atrial lead implantation in the Bachmann bundle
Heart RhythmVol. 2Issue 7p784–786Published online: March 22, 2005- Steven J. Bailin
Cited in Scopus: 7The search for alternative atrial pacing sites has been driven by the observation that atrial activation patterns can influence the incidence of atrial fibrillation (AF).1,2 One goal of atrial pacing is to prevent nonphysiologic delay between right and left atrial activation. Pacing from atrial sites that decrease dispersion of atrial refractoriness may decrease the incidence of AF. - Hands on
Using the twelve-lead electrocardiogram to localize the site of origin of ventricular tachycardia
Heart RhythmVol. 2Issue 4p443–446Published online: March 11, 2005- Mark E. Josephson
- David J. Callans
Cited in Scopus: 59The basis of this review is the underlying hypothesis that the QRS morphology on 12-lead ECG is, to a great extent, determined by the site from which a focal ventricular tachycardia (VT) arises or from which a reentrant circuit exits the central isthmus to activate the “normal” myocardium. The ability to localize or, at the very least, regionalize “the sites of origin” of VTs enables the electrophysiologist to concentrate mapping to a specific region. Several factors limit the ability of the QRS patterns to localize VT origin, including (1) presence and size of infarction, (2) degree of intramyocardial fibrosis, (3) shape of the heart (e.g., aneurysm) and its position within the chest cavity, (4) site and mechanism of VT within an infarct or scarred area, (5) influence of nonuniform anisotropy in affecting propagation from the site of the tachycardia, (6) effects of acute ischemia, antiarrhythmic drugs, or metabolic abnormalities on conduction, (7) integrity of the His-Purkinje system, (8) presence of increased myocardial mass, and (9) presence of structural abnormalities unrelated to tachycardia origin or mechanisms.